Characteristics of adults with persistent cough in general practice

B. B. P. Ponsioen, W. W. C. J. Hop, N. N. A. Vermue, A. A. M. Bohnen (Rotterdam, The Netherlands)

Source: Annual Congress 2002 - Aspects of respiratory disease in primary care
Session: Aspects of respiratory disease in primary care
Session type: Thematic Poster Session
Number: 2986
Disease area: Airway diseases

Congress or journal article abstract

Abstract

Persistent cough may be associated with bronchial hyperresponsiveness and/or smoking. We analysed the baseline data of the participants of a general practice, single-centre, randomised, double-blind, placebo controlled parallel group study to determine the effect of a 2 weeks treatment with fluticasone propionate 2 x 250 mcg bd MDI via Volumatic spacer in patients with persistent cough (two weeks and over) and/or acute bronchitis (without asthma or COPD).
Participants: N=135, age range: 18-65y, women: 64%, bronchial hyperresponsive (PD20): 38%, allergy (RAST): 22%, smokers: 37% and FEV1% pred: mean 101%. Results: Mean FEV1 % pred in patients with normal PD20 was 107% and in patients with mild/moderate PD20 was 92% (p<0.001). Difference in PD20 between allergy y/n was small: median 1.80 mg (allergy) vs more than 2.00 mg histamine (no allergy) (p=0.011). There was no relationship between problems with environmental factors (AQLQ, Juniper) and PD20 measured in our patients, neither in smokers nor in non-smokers. Smokers of all ages had mean FEV1% pred lower than non-smokers (96% vs 105% pred, p=0.003). Baseline cough score (last 24 h) was weakly related (r=-0.21, p=0.02) to limitations by cough during the last 2 weeks. However, stronger relationships (r=-0.43 and r=–0,44, p<0.001) were found between baseline night-cough score (last 24 h) and awakenings by cough last night vs. interference (during the last 2 weeks) with getting a good night's sleep because of cough. Further results on the effect of fluticasone propionate will be presented.
In conclusion: Symptoms due to environmental factors do not predict hyperresponsiveness (PD20). FEV1%pred and problems with cough during the last night showed the strongest correlation with limitations due to persistent cough in primary care.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
B. B. P. Ponsioen, W. W. C. J. Hop, N. N. A. Vermue, A. A. M. Bohnen (Rotterdam, The Netherlands). Characteristics of adults with persistent cough in general practice. Eur Respir J 2002; 20: Suppl. 38, 2986

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Prediction model for COPD in people presenting cough in general practice
Source: Annual Congress 2009 - COPD case-finding and management in primary care
Year: 2009


Prevalence and characteristics of chronic cough in a general population study
Source: International Congress 2019 – Highlights in lung function and chronic cough
Year: 2019


Persistence of chronic cough in a community-based population
Source: ERJ Open Res, 6 (2) 00229-2019; 10.1183/23120541.00229-2019
Year: 2020



Etiology of chronic cough in a population of children referred to a pediatric pulmonologist
Source: Eur Respir J 2002; 20: Suppl. 38, 534s
Year: 2002

Persistent cough evaluation in children
Source: Annual Congress 2009 - Diagnostic tools in paediatric respiratory infection
Year: 2009



A comparison of patients with chronic cough referred to a specialist cough and a general respiratory clinic
Source: Annual Congress 2013 –Modern approach to various clinical settings
Year: 2013

Prevalence of chronic cough, patient characteristics and health outcomes among UK adults
Source: International Congress 2019 – COPD: epidemiology and spirometry
Year: 2019


Management of cough in adults
Source: Breathe 2010; 7: 122-133
Year: 2010

Role and impact of chronic cough in obese individuals from the general population
Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases
Year: 2020


Outcome of chronic cough referrals seen in general respiratory clinic
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011


Prevalence of COPD in a general practice population
Source: Eur Respir J 2005; 26: Suppl. 49, 591s
Year: 2005

Characteristics and outcomes of chronic cough in individuals with asthma: a population-based study
Source: International Congress 2018 – Asthma and allergy in adults and children and their biomarkers
Year: 2018




Symptoms related to asthma and chronic bronchitis in general population
Source: Eur Respir J 2005; 26: Suppl. 49, 379s
Year: 2005

Outcomes of chronic unexplained cough in schoolchildren
Source: Eur Respir J 2004; 24: Suppl. 48, 48s
Year: 2004

Psychological profile of individuals presenting with chronic cough
Source: ERJ Open Res, 3 (1) 00099-2016; 10.1183/23120541.00099-2016
Year: 2017



The noctil study: caring for nocturnal asthma symptoms in adults
Source: Eur Respir J 2002; 20: Suppl. 38, 80s
Year: 2002

What are the consequences of chronic cough and expectoration for health status among patients with COPD?
Source: Eur Respir J 2003; 22: Suppl. 45, 577s
Year: 2003

Evaluation of vocal performance questionnaire in people with chronic refractory cough
Source: Annual Congress 2013 –Assessment methods involved in the physiotherapy treatment in different patient populations
Year: 2013


Uncommon causes of chronic cough in non-smoking adults.
Source: International Congress 2019 – Chronic cough, a1-antitrypsin deficiency and other conditions
Year: 2019

Algorythm of differential diagnostics and further management of cough variant asthma in patients with chronic cough
Source: Eur Respir J 2003; 22: Suppl. 45, 372s
Year: 2003